A GLOBAL LEADER
IN GENE THERAPY

Homepage icon r and d

Research & Development

Our mission at uniQure is to deliver curative gene therapies that transform the lives of patients. We have an ongoing clinical program in hemophilia B and preclinical proof-of-concept for a gene therapy in Huntington's disease.

Learn More

Homepage icon news

News & Events

uniQure Announces License Agreement with
CSL Behring to Commercialize
Hemophilia B Gene Therapy.

Click here to view press release.

Latest News

Homepage icon careers

Join Us!

uniQure is always on the look-out for talent and highly motivated and skilled people who want to make a difference. From technical level positions up to management, uniQure has a lot to offer.

Careers